Thursday, August 13, 2026

Pyongyang Denounces Iron Mace Exercise, Vows Stronger Nuclear Deterrence

North Korea criticizes the Iron Mace exercise, claiming it exacerbates military tensions and threatens regional stability.

KAIST Team Develops High-Efficiency, Long-Life AEM Water Electrolysis Technology for Green Hydrogen

KAIST researchers developed a design technology ensuring both performance and stability in anion exchange membrane water electrolysis.

North Korean Hackers Hiding in Plain Sight at U.S. Companies

North Korean IT workers are using Chinese shell companies to infiltrate Western firms, raising concerns about security and intellectual property theft.

Tag: CT-P55

Celltrion’s CT-P55: What Changes to FDA Clinical Trials Mean for Biosimilarity with Cosentyx?

Celltrion has applied to the FDA for changes to its Phase 3 trial of CT-P55, reducing participants to 153 to assess biosimilarity to Cosentyx.

CT-P55: How Celltrion’s New Biosimilar Approval Will Transform Clinical Trials in Europe

Celltrion receives EMA approval to reduce patient enrollment for CT-P55 trial, aiming to cut costs and duration of clinical development.

Top News

- Our Sponsors Ad -

Follow us